Prognosis Following Discontinuation of OnabotulinumA Therapy in "Super-responding" Chronic Migraine Patients.

Authors

Jason Ching, George Washington University
Amanda Tinsley, George Washington University
John Rothrock, George Washington University

Document Type

Journal Article

Publication Date

9-1-2019

Journal

Headache

Volume

59

Issue

8

Inclusive Pages

1279-1285

DOI

10.1111/head.13630

Comments

Epub 2019 Sep 9

APA Citation

Ching, J., Tinsley, A., & Rothrock, J. (2019). Prognosis Following Discontinuation of OnabotulinumA Therapy in "Super-responding" Chronic Migraine Patients.. Headache, 59 (8). http://dx.doi.org/10.1111/head.13630

Peer Reviewed

1